Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.29)
# 933
Out of 4,829 analysts
83
Total ratings
33.33%
Success rate
6.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $76.76 | +88.90% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $14.58 | +249.79% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $0.70 | +755.92% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $4.06 | +1,082.27% | 1 | Feb 28, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $94 → $110 | $7.43 | +1,380.48% | 2 | Feb 26, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $32.49 | +186.24% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $8.82 | +750.34% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $0.59 | +1,089.06% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $6.57 | +295.74% | 2 | Oct 30, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $18.37 | +101.42% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $1.21 | +2,048.76% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $20 | $2.36 | +749.26% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $1.01 | +2,672.28% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $30.68 | +216.17% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $38.35 | +604.04% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $19.76 | +284.62% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $5.59 | +347.23% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $13.63 | +120.10% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $3.50 | +242.86% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $63.32 | -43.15% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.55 | +1,536.36% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $15.42 | +1,067.32% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $1.11 | +1,251.35% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $299.69 | +12.12% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.86 | +459.44% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $19.62 | +307.75% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $25.57 | +263.71% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $15.10 | +330.46% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $14.02 | +306.56% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $3.26 | +1,955.21% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $42.95 | -18.51% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $22 | $0.33 | +6,607.32% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $5.27 | +1,550.85% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $4.48 | +3,806.25% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $31.70 | +127.17% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $1.41 | +1,814.89% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $7.71 | +146.59% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $1.24 | +3,932.26% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.41 | +9,564.17% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.42 | +4,189.80% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $10.38 | +3,946.24% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $10.98 | +601.28% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $44.27 | +73.93% | 1 | Jul 31, 2020 |
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $76.76
Upside: +88.90%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $14.58
Upside: +249.79%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $0.70
Upside: +755.92%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $4.06
Upside: +1,082.27%
Prothena Corporation
Feb 26, 2025
Maintains: Overweight
Price Target: $94 → $110
Current: $7.43
Upside: +1,380.48%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $32.49
Upside: +186.24%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $8.82
Upside: +750.34%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $0.59
Upside: +1,089.06%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $6.57
Upside: +295.74%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $18.37
Upside: +101.42%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.21
Upside: +2,048.76%
Aug 14, 2024
Maintains: Overweight
Price Target: $68 → $20
Current: $2.36
Upside: +749.26%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.01
Upside: +2,672.28%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $30.68
Upside: +216.17%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $38.35
Upside: +604.04%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $19.76
Upside: +284.62%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $5.59
Upside: +347.23%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $13.63
Upside: +120.10%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $3.50
Upside: +242.86%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $63.32
Upside: -43.15%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.55
Upside: +1,536.36%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $15.42
Upside: +1,067.32%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.11
Upside: +1,251.35%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $299.69
Upside: +12.12%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.86
Upside: +459.44%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $19.62
Upside: +307.75%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $25.57
Upside: +263.71%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $15.10
Upside: +330.46%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $14.02
Upside: +306.56%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $3.26
Upside: +1,955.21%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $42.95
Upside: -18.51%
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $0.33
Upside: +6,607.32%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $5.27
Upside: +1,550.85%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $4.48
Upside: +3,806.25%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $31.70
Upside: +127.17%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $1.41
Upside: +1,814.89%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $7.71
Upside: +146.59%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $1.24
Upside: +3,932.26%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.41
Upside: +9,564.17%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.42
Upside: +4,189.80%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $10.38
Upside: +3,946.24%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $10.98
Upside: +601.28%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $44.27
Upside: +73.93%